Back to search

Institutes outside Greece

Regulation of bone morphogenetic growth factor bioavailability by the extracellular matrix

Abstract

dc:description

Bone morphogenetic proteins (BMPs) belong to the TGF-β superfamily of pluripotent growth factors that exert several critical cellular functions such as proliferation, differentiation, and apoptosis during development and tissue homeostasis. Although originally discovered as extractable cytokines from bone matrix, it has not been investigated how the extracellular matrix controls their bioavailability. Gaining a better understanding about the molecular requirements controlling BMP activity within extracellular tissue microenvironments is crucial for new therapeutic advances in connective tissue disease and tissue regeneration. BMPs are synthesized as single chain precursors consisting of a prodomain (PD) and a growth factor (GF) moiety that are processed by proproteinconvertases (PPCs) to form a non-covalently associated PD-GF complex (CPLX). By employing transmission electron microscopy (TEM) with single particle averaging, molecular docking and bioactivity assays, it was discovered that PPC processing induces a conformational change that renders BMP-10 CPLX signaling-competent. Since BMP-10 predominantly circulates in human plasma as an unprocessed variant, its bioactivity can thus be regulated by the availability of PPCs within the extracellular space. In addition, the ECM can regulate BMP bioactivity by specific PD mediated targeting of BMP CPLXs to the microfibril component fibrillin-1. It was shown previously that the bioactive V-shape of BMP-7 CPLX assumes a latent, closed-ring conformation when targeted to fibrilin-1. In contrast, by employing negative staining EM and bioactivity assays on solid phase, it could be demonstrated that BMP-7 and BMP-9 CPLX targeting to heparin/ HS maintains their bioactive state. Molecular modeling, docking and heparin binding studies pointed towards conserved heparin/ HS bindingepitopes residing within the PD arm regions. In order to shed light into activation mechanisms of the fibrillin-bound BMPs, a cleavage screen using several matrix metalloproteinases (MMPs), combined with Edman sequencing and mutagenesis were employed that pointed towards a conserved PD cleavage consensus. By employing bioactivity assays, EM with single particle averaging and native PAGE it was found that MMP-13 releases bioactive GF leading to CPLX unfolding. In summary, this thesis provides a comprehensive analysis of different mechanisms utilized by the ECM to control BMP bioactivity in distinct extracellular microenvironments.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Spanou, Charikleia
  • Σπανού, Χαρίκλεια

Subjects

dc:subject × 26

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61028

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Spanou, Charikleia; Σπανού, Χαρίκλεια. Regulation of bone morphogenetic growth factor bioavailability by the extracellular matrix. Institutes outside Greece, 2022. http://hdl.handle.net/10442/hedi/61028